Immunome Inc (IMNM)
14.40
-0.02
(-0.14%)
USD |
NASDAQ |
May 23, 10:27
Immunome Market Cap: 863.55M for May 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 22, 2024 | 864.75M |
| May 21, 2024 | 818.58M |
| May 20, 2024 | 827.57M |
| May 17, 2024 | 829.37M |
| May 16, 2024 | 863.55M |
| May 15, 2024 | 887.54M |
| May 14, 2024 | 882.74M |
| May 13, 2024 | 936.11M |
| May 10, 2024 | 929.52M |
| May 09, 2024 | 928.32M |
| May 08, 2024 | 941.51M |
| May 07, 2024 | 919.32M |
| May 06, 2024 | 927.12M |
| May 03, 2024 | 944.11M |
| May 02, 2024 | 897.35M |
| May 01, 2024 | 880.57M |
| April 30, 2024 | 842.80M |
| April 29, 2024 | 828.42M |
| April 26, 2024 | 823.02M |
| April 25, 2024 | 854.79M |
| April 24, 2024 | 851.90M |
| April 23, 2024 | 875.19M |
| April 22, 2024 | 912.20M |
| April 19, 2024 | 924.14M |
| April 18, 2024 | 1.026B |
| Date | Value |
|---|---|
| April 17, 2024 | 1.038B |
| April 16, 2024 | 1.098B |
| April 15, 2024 | 1.125B |
| April 12, 2024 | 1.229B |
| April 11, 2024 | 1.255B |
| April 10, 2024 | 1.214B |
| April 09, 2024 | 1.223B |
| April 08, 2024 | 1.202B |
| April 05, 2024 | 1.210B |
| April 04, 2024 | 1.210B |
| April 03, 2024 | 1.289B |
| April 02, 2024 | 1.277B |
| April 01, 2024 | 1.320B |
| March 28, 2024 | 1.473B |
| March 27, 2024 | 1.523B |
| March 26, 2024 | 1.516B |
| March 25, 2024 | 1.424B |
| March 22, 2024 | 1.390B |
| March 21, 2024 | 1.380B |
| March 20, 2024 | 1.379B |
| March 19, 2024 | 1.377B |
| March 18, 2024 | 1.263B |
| March 15, 2024 | 1.285B |
| March 14, 2024 | 1.283B |
| March 13, 2024 | 1.355B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
26.80M
Minimum
Dec 30 2022
1.563B
Maximum
Mar 07 2024
241.27M
Average
117.55M
Median
Market Cap Benchmarks
| Ayala Pharmaceuticals Inc | 9.371M |
| Exelixis Inc | 6.027B |
| CEL-SCI Corp | 69.87M |
| AIM ImmunoTech Inc | 20.51M |
| IGC Pharma Inc | 31.94M |
Market Cap Related Metrics
| PS Ratio | 22.13 |
| Price to Book Value | 3.024 |
| Price | 14.40 |
| Earnings Yield | -107.7% |